ZNF316

gene
On this page

Also known as MZF-3ENST00000305834

Summary

ZNF316 (zinc finger protein 316, HGNC:13843) is a protein-coding gene on chromosome 7p22.1, encoding Zinc finger protein 316 (A6NFI3). May be involved in transcriptional regulation.

Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.

Source: NCBI Gene 100131017 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 10 total
  • MANE Select transcript: NM_001278559

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:13843
Approved symbolZNF316
Namezinc finger protein 316
Location7p22.1
Locus typegene with protein product
StatusApproved
AliasesMZF-3, ENST00000305834
Ensembl geneENSG00000205903
Ensembl biotypeprotein_coding
Entrez100131017

Gene structure

Transcript identifiers

Ensembl transcripts: 13 — 12 protein_coding, 1 retained_intron

ENST00000382252, ENST00000427912, ENST00000614588, ENST00000949893, ENST00000949894, ENST00000949895, ENST00000949896, ENST00000949897, ENST00000949898, ENST00000949899, ENST00000949900, ENST00000949901, ENST00000949902

RefSeq mRNA: 1 — MANE Select: NM_001278559 NM_001278559

CCDS: CCDS75563

Canonical transcript exons

ENST00000382252 — 9 exons

ExonStartEnd
ENSE0000149140566523036658279
ENSE0000159443366418256641962
ENSE0000163755066390426639141
ENSE0000166548866423826642764
ENSE0000175368666378466638009
ENSE0000177413866373186637447
ENSE0000355897566438226643948
ENSE0000362430766429646643073
ENSE0000368492966444806644593

Expression profiles

Bgee: expression breadth ubiquitous, 221 present calls, max score 92.93.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 15.0125 / max 371.8702, expressed in 1803 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
7716511.00171783
771662.98821320
771641.0226709

Top tissues by expression

243 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
kidney epitheliumUBERON:000481992.93silver quality
granulocyteCL:000009492.82gold quality
right lobe of thyroid glandUBERON:000111990.98gold quality
left lobe of thyroid glandUBERON:000112090.15gold quality
sural nerveUBERON:001548889.73gold quality
thyroid glandUBERON:000204689.25gold quality
monocyteCL:000057689.24gold quality
leukocyteCL:000073889.05gold quality
body of uterusUBERON:000985388.62gold quality
spleenUBERON:000210688.58gold quality
vermiform appendixUBERON:000115488.35gold quality
cortical plateUBERON:000534388.26gold quality
stromal cell of endometriumCL:000225587.87gold quality
esophagogastric junction muscularis propriaUBERON:003584187.81gold quality
muscle layer of sigmoid colonUBERON:003580587.80gold quality
mucosa of stomachUBERON:000119987.75gold quality
caecumUBERON:000115387.58gold quality
skin of legUBERON:000151187.53gold quality
right uterine tubeUBERON:000130287.37gold quality
lower esophagus muscularis layerUBERON:003583387.36gold quality
lower esophagusUBERON:001347387.35gold quality
apex of heartUBERON:000209887.32gold quality
skin of abdomenUBERON:000141687.13gold quality
left uterine tubeUBERON:000130387.10gold quality
right coronary arteryUBERON:000162587.01gold quality
body of stomachUBERON:000116186.84gold quality
right adrenal gland cortexUBERON:003582786.61gold quality
small intestine Peyer’s patchUBERON:000345486.58gold quality
metanephros cortexUBERON:001053386.56gold quality
fundus of stomachUBERON:000116086.42gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no3.32

Regulation

Is transcription factor: yes

Downstream targets (CollecTRI)

4 targets.

TargetRegulation
PDLIM7
RGS2
S100A9
TRIM28

miRNA regulators (miRDB)

108 targeting ZNF316, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4283100.0066.422097
HSA-MIR-1252-5P100.0069.802774
HSA-MIR-12118100.0065.881270
HSA-MIR-4510100.0066.602050
HSA-MIR-6127100.0066.762188
HSA-MIR-6129100.0066.462080
HSA-MIR-6130100.0066.692012
HSA-MIR-6133100.0066.482064
HSA-MIR-513B-5P99.9969.962150
HSA-MIR-6759-5P99.9966.54785
HSA-MIR-10401-5P99.9965.79948
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-3688-3P99.9772.022834
HSA-MIR-512-3P99.9767.351049
HSA-MIR-6778-3P99.9667.292693
HSA-MIR-9-3P99.9670.882068
HSA-MIR-211099.9666.681930
HSA-MIR-651-3P99.9473.485177
HSA-MIR-4731-5P99.8967.232537
HSA-MIR-807399.8665.211118
HSA-MIR-4728-5P99.8569.394718
HSA-MIR-444799.8567.812900
HSA-MIR-629-3P99.8567.991875
HSA-MIR-6785-5P99.8268.684428
HSA-MIR-320A-3P99.7769.732107
HSA-MIR-320B99.7769.732107
HSA-MIR-320C99.7769.732107
HSA-MIR-320D99.7769.732107
HSA-MIR-442999.7769.622111
HSA-MIR-6764-5P99.7567.892304

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusZfp316ENSMUSG00000046658
rattus_norvegicusZfp316ENSRNOG00000001094

Paralogs (1): ZNF787 (ENSG00000142409)

Protein

Protein identifiers

Zinc finger protein 316A6NFI3 (reviewed: A6NFI3)

All UniProt accessions (2): A0A087WZ61, A6NFI3

UniProt curated annotations — full annotation on UniProt →

Function. May be involved in transcriptional regulation.

Subcellular location. Nucleus.

Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.

RefSeq proteins (1): NP_001265488* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001909KRABDomain
IPR013087Znf_C2H2_typeDomain
IPR036051KRAB_dom_sfHomologous_superfamily
IPR036236Znf_C2H2_sfHomologous_superfamily

Pfam: PF00096, PF01352

UniProt features (33 total): zinc finger region 15, compositionally biased region 6, modified residue 4, region of interest 3, cross-link 2, initiator methionine 1, chain 1, domain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-A6NFI3-F160.880.02

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (6): 2, 7, 10, 112, 829, 955

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 29 (showing top): chr7p22, GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN, CHYLA_CBFA2T3_TARGETS_DN, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, FOXN3_TARGET_GENES, TFEB_TARGET_GENES, MIR6778_3P, MIR4283, MIR6842_3P, MIR7855_5P, MIR212_5P, MIR4795_5P, MIR4772_5P

GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)

GO Molecular Function (5): DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), sequence-specific DNA binding (GO:0043565), DNA binding (GO:0003677), metal ion binding (GO:0046872)

GO Cellular Component (1): nucleus (GO:0005634)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
regulation of DNA-templated transcription1
transcription by RNA polymerase II1
DNA-templated transcription1
regulation of gene expression1
regulation of RNA biosynthetic process1
chromatin1
RNA polymerase II transcription regulatory region sequence-specific DNA binding1
DNA-binding transcription factor activity1
regulation of transcription by RNA polymerase II1
transition metal ion binding1
DNA binding1
nucleic acid binding1
cation binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

768 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZNF316C2orf68Q2NKX9480
ZNF316HDDC2Q7Z4H3462
ZNF316PXDC1Q5TGL8415
ZNF316F5GXR3F5GXR3374
ZNF316METTL15A6NJ78370
ZNF316ASCL5Q7RTU5370
ZNF316ZNF512Q96ME7356
ZNF316IGHV3-11P01762356
ZNF316NDOR1Q9UHB4354
ZNF316KCNN2Q9H2S1299
ZNF316SLC25A31Q9H0C2282
ZNF316COPG2Q9UBF2272
ZNF316NEDD1Q8NHV4257
ZNF316GPATCH8Q9UKJ3257
ZNF316ABCA6Q8N139256

IntAct

76 interactions, top by confidence:

ABTypeScore
ZNF764ZNF316psi-mi:“MI:0914”(association)0.640
ZNF764SH3PXD2Bpsi-mi:“MI:0914”(association)0.530
ZNF169ZNF316psi-mi:“MI:0914”(association)0.530
ZNF324BZNF316psi-mi:“MI:0914”(association)0.530
ZNF707ZNF316psi-mi:“MI:0914”(association)0.530
VWCEZNF316psi-mi:“MI:0914”(association)0.530
CACNG5ZNF316psi-mi:“MI:0914”(association)0.530
NRBM47psi-mi:“MI:0914”(association)0.530
TRIM28ZNF316psi-mi:“MI:0914”(association)0.530
RPS3ZNF316psi-mi:“MI:0914”(association)0.530
FBLZNF316psi-mi:“MI:0914”(association)0.530
TRIM28ZNF320psi-mi:“MI:0914”(association)0.530
ABT1ZNF316psi-mi:“MI:0914”(association)0.530
MAGEB2GTPBP10psi-mi:“MI:0914”(association)0.530
NOTCH2ZNF316psi-mi:“MI:0914”(association)0.530
ZNF316psi-mi:“MI:0914”(association)0.350
FBLGXYLT2psi-mi:“MI:0914”(association)0.350
EFEMP1ZNF316psi-mi:“MI:0914”(association)0.350
NRBM47psi-mi:“MI:0914”(association)0.350

BioGRID (73): ZNF316 (Affinity Capture-MS), ZNF316 (Affinity Capture-MS), ZNF316 (Affinity Capture-MS), ZNF316 (Affinity Capture-MS), ZNF316 (Affinity Capture-MS), ZNF316 (Affinity Capture-MS), ZNF316 (Affinity Capture-MS), ZNF316 (Affinity Capture-MS), ZNF316 (Affinity Capture-MS), ZNF316 (Affinity Capture-MS), ZNF316 (Affinity Capture-MS), ZNF316 (Affinity Capture-MS), ZNF316 (Affinity Capture-MS), ZNF316 (Affinity Capture-MS), ZNF316 (Affinity Capture-MS)

ESM2 similar proteins: A0A2Z4LIS9, A2CE44, A6NFI3, E9PZZ1, O95201, P09066, P15863, P19622, P22091, P46099, P49640, P70338, P82976, P97503, P98168, P98169, Q05917, Q07120, Q13351, Q14549, Q14V87, Q15270, Q19A40, Q2QGD7, Q3SY56, Q3U133, Q58DK7, Q5DWN0, Q6IQX8, Q6NUN9, Q8C8V1, Q8NCA9, Q8TD94, Q8WUU4, Q924A2, Q92618, Q96RK0, Q99684, Q9BV97, Q9BYN7

Diamond homologs: A0JPL0, A2A761, A3KN32, A3KN36, A6NFI3, A6NM28, A6QLU5, A6QPT6, A7MBI1, A8MTY0, B2RXC5, B4DU55, E9PYI1, O14978, O60765, O75467, O75820, O95780, P0C7X2, P0DKX0, P0DPD5, P10072, P15622, P16374, P17014, P17023, P17032, P17098, P51523, P51786, P52738, P52742, Q02975, Q06732, Q08DG8, Q08ER8, Q0VCB0, Q14590, Q14929, Q29RZ4

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 56 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Peptide chain elongation830.8×7e-09
Viral mRNA Translation830.8×7e-09
PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA830.4×7e-09
Selenocysteine synthesis829.1×7e-09
Eukaryotic Translation Termination829.1×7e-09
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)828.5×7e-09
ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA828.5×7e-09
Formation of a pool of free 40S subunits827.1×9e-09

GO biological processes:

GO termPartnersFoldFDR
cytoplasmic translation829.1×8e-08
rRNA processing513.9×3e-03
translation612.1×1e-03

Disease & clinical

Clinical variants and AI predictions

ClinVar

10 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance1
Likely benign2
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1227 predictions. Top by Δscore:

VariantEffectΔscore
7:6642763:GG:Gdonor_gain1.0000
7:6642764:GG:Gdonor_gain1.0000
7:6642962:A:AGacceptor_gain1.0000
7:6642962:AG:Aacceptor_gain1.0000
7:6642963:G:GAacceptor_gain1.0000
7:6642963:GG:Gacceptor_gain1.0000
7:6642963:GGC:Gacceptor_gain1.0000
7:6642963:GGCC:Gacceptor_gain1.0000
7:6642963:GGCCT:Gacceptor_gain1.0000
7:6643068:TGTC:Tdonor_gain1.0000
7:6643074:G:Cdonor_loss1.0000
7:6643820:A:AGacceptor_gain1.0000
7:6643820:AG:Aacceptor_gain1.0000
7:6643821:G:GTacceptor_gain1.0000
7:6643821:GG:Gacceptor_gain1.0000
7:6643821:GGA:Gacceptor_gain1.0000
7:6643821:GGAGC:Gacceptor_gain1.0000
7:6643909:G:GTdonor_gain1.0000
7:6643909:G:Tdonor_gain1.0000
7:6643921:G:GTdonor_gain1.0000
7:6643947:GG:Gdonor_gain1.0000
7:6643948:GG:Gdonor_gain1.0000
7:6643949:G:GGdonor_gain1.0000
7:6643949:GTA:Gdonor_loss1.0000
7:6644474:T:Aacceptor_gain1.0000
7:6644475:GGCA:Gacceptor_loss1.0000
7:6644476:GCAG:Gacceptor_loss1.0000
7:6644478:A:AGacceptor_gain1.0000
7:6644478:A:Gacceptor_loss1.0000
7:6644478:AG:Aacceptor_gain1.0000

AlphaMissense

6474 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
7:6652740:T:CF382L1.000
7:6652742:C:AF382L1.000
7:6652742:C:GF382L1.000
7:6652803:T:CC403R1.000
7:6652824:T:CF410L1.000
7:6652825:T:CF410S1.000
7:6652826:C:AF410L1.000
7:6652826:C:GF410L1.000
7:6653778:T:CF728L1.000
7:6653780:C:AF728L1.000
7:6653780:C:GF728L1.000
7:6654030:T:CF812L1.000
7:6654032:C:AF812L1.000
7:6654032:C:GF812L1.000
7:6654114:T:CF840L1.000
7:6654116:C:AF840L1.000
7:6654116:C:GF840L1.000
7:6654198:T:CF868L1.000
7:6654200:C:AF868L1.000
7:6654200:C:GF868L1.000
7:6654282:T:CF896L1.000
7:6654283:T:CF896S1.000
7:6654284:T:AF896L1.000
7:6654284:T:GF896L1.000
7:6654309:C:GH905D1.000
7:6654366:T:CF924L1.000
7:6654367:T:CF924S1.000
7:6654368:C:AF924L1.000
7:6654368:C:GF924L1.000
7:6652741:T:CF382S0.999

dbSNP variants (sampled 300 via entrez): RS1000187747 (7:6648682 CCAGA>C), RS1000220171 (7:6650299 C>G,T), RS1000267950 (7:6641460 G>C), RS1000344458 (7:6650509 G>A), RS1000519321 (7:6646289 G>T), RS1000635205 (7:6646533 C>T), RS1000780666 (7:6656556 A>G), RS1000860873 (7:6650688 A>T), RS1000868594 (7:6642622 G>A), RS1000913354 (7:6636370 C>A,T), RS1000944459 (7:6637222 C>A,G), RS1000966813 (7:6636587 C>G), RS1001104542 (7:6641437 C>A,G,T), RS1001195295 (7:6648076 T>C), RS1001320833 (7:6643624 TTTGAGC>T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

22 total (human), top 22 by PubMed support.

ChemicalActions (top 5)PubMed papers
Air Pollutantsincreases abundance, increases expression, affects expression3
Particulate Matterincreases abundance, increases expression2
afuresertibdecreases expression1
FR900359increases phosphorylation1
triphenyl phosphateaffects expression1
propionaldehydeincreases expression1
sodium arseniteincreases expression1
butyraldehydeincreases expression1
benzo(e)pyrenedecreases methylation1
coumarinaffects phosphorylation1
pentanalincreases expression1
abrineincreases expression1
Cadmiumincreases abundance, increases expression1
Caffeineincreases phosphorylation1
Dichlorodiphenyl Dichloroethylenedecreases expression1
Doxorubicindecreases expression1
Methapyrilenedecreases methylation1
Ozoneaffects expression, increases abundance1
Quercetindecreases phosphorylation1
Smokedecreases expression1
Thiramincreases expression1
Cadmium Chlorideincreases abundance, increases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.